Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

Joerg Steier, ATS 2022: Challenges and Advances in the Treatment of Obstructive Sleep Apnea

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 19th 2022

We were delighted to talk with Professor Joerg Steier (King’s College London, London, UK) to learn more around the challenges involved in the treatment of excessive daytime sleepiness in patients with obstructive sleep apnea and the latest research to look out for in 2022.

The abstract ‘Development of Delphi Consensus Statements on the Differential Diagnosis and Management of Excessive Daytime Sleepiness in Obstructive Sleep Apnea.‘ (Abstract no. P58) was presented at ATS 2022, 13-18 May 2022.

Questions

  1. What are the challenges in the treatment of excessive daytime sleepiness in patients with obstructive sleep apnea? (0:30)
  2. What are the hot topics and latest research you are looking forward to exploring in obstructive sleep apnea in 2022? (2:07)

Disclosures: Joerg Steier has served on advisory boards for JazzPharmaceuticals and has received honoraria from JazzPharmaceuticals.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the ATS meeting 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup